Cancer Letters

Cancer Letters

Volume 421, 1 May 2018, Pages 82-93
Cancer Letters

Original Articles
Disruption of peroxisome function leads to metabolic stress, mTOR inhibition, and lethality in liver cancer cells

https://doi.org/10.1016/j.canlet.2018.02.021Get rights and content

Highlights

  • Peroxisome function is essential in liver cancer cells.

  • Normal peroxisome function maintains the activity of mTORC1.

  • Autophagy in liver cancer cells is induced by dysfunctional peroxisomes.

Abstract

Peroxisome houses a large number of enzymes involved in lipid and phytochemical oxidation as well as synthesis of bile acid and other specialized lipids. Peroxisome resident enzymes are imported into the organelle via a conserved cargo transport system composed of many peroxins, protein factors essential for the biogenesis of peroxisome. Among the peroxins, PEX5 plays a transporter role, and PEX2, 10, and 12 are thought to form a complex that functions as an E3 ubiquitin ligase to help recycle PEX5 in an ubiquitin modification-dependent process. Previous studies have demonstrated the importance of peroxins in postnatal development especially the development of nerve systems. These studies also show that peroxins or the function of peroxisomes is dispensable for cellular viability. In contrast, however, we report here that PEX2 and other peroxins are essential for the viability of liver cancer cells, probably through altering metabolism and signaling pathways. Our results suggest that peroxins may be potential targets of therapeutics against liver cancer.

Introduction

Peroxisome is a cellular organelle that performs diverse metabolic functions in virtually all eukaryotic cells, including the α- and β-oxidation of fatty acids, cholesterol metabolism, the biosynthesis of bile acids and ether phospholipids, and metabolism of reactive oxygen species (ROS) [1,2]. The biogenesis of peroxisome occurs either by de novo production through budding off the endoreticulum or by the growth and fission of existing organelle [3]. The importation of matrix proteins into peroxisome is carried out by a group of proteins named peroxins (PEXs). PEX5 and PEX7, are carriers which recognize peroxisome targeting signal (PTS1 and PTS2, respectively) in the cargo proteins and transport cargos from cytoplasm onto the surface of peroxisome where they interact with other peroxins to release the cargo into a putative tunnel formed by PEX14 and PEX13, and leave the organelle for another round of importation [[4], [5], [6]]. Although the mechanisms of both cargo and PEX5 (and PEX7) release are still sketchy, it is clear that ubiquitin modification plays an essential role in the process [7,8]. PEX2, 10, and 12 form a ubiquitin E3 ligase complex that modifies PEX5 and promotes PEX5 release from peroxisome into cytoplasm [9,10]. The majority of peroxisome matrix proteins carries PTS1 and therefore are PEX5-dependent for their import into peroxisome.

Intact peroxisomal function is critical for human health and normal development, as defects in peroxisome cause a group of heterogeneous and devastating genetic disorders [9]. There are two categories of peroxisomal disorders: single peroxisomal enzyme deficiency and peroxisome biogenesis disorder (PBD). PBD includes two distinct subtypes: rhizomelic chondrodysplasia punctate type 1 and the Zellweger spectrum disorder [11,12], both of which are linked to mutations in peroxin genes [13]. The Zellweger spectrum disorder is a group of disease conditions, including (from severe to mild) Zellweger syndrome (ZS), neonatal adrenoleukodystrophy (NALD), and infantile Refsum disease. PEX2 was the first peroxin found mutated in Zellweger syndrome [14,15]. Most patients with ZS are characterized by brain morphology changes, including cortical gyral abnormalities, focal or generalized leukoencephalopathy, and brain atrophy [12]. These conditions can all be attributed to defects in the myelination of nerves, although how exactly peroxisomes function in myelin sheeth has not been fully characterized [16,17]. Despite the devastating consequences of peroxisome disorders, peroxisome is apparently dispensable for cellular viability as evidenced by the normal growth of peroxisome-free yeasts [18] and cells derived from patients with Zellweger syndrome [13] or mice with peroxin knockouts [19].

Cancer cells often alter metabolism to support their malignant phenotype. The most noticeably changes in cancer cell metabolism is the Warburg effect [20]. Given the important roles played by peroxisome in metabolism, we sought to determine if the function of this organelle is crucial for cancer cells. Here we report that disruption of peroxisome results in profound metabolic alterations in liver cancer cells that eventually lead to their cessation of proliferation.

Section snippets

Reagents

Dulbecco's modified Eagle's medium (DMEM), RPMI-1640 Medium, fetal bovine serum (FBS), and antibiotics were purchased from Gibco (Grand Island, NY). The antibodies used in this study were as follows: antibodies against phospho-4E-BP1 (T37/46; #2855, 1:1000 WB), phospho-S6K (T389; #9205, 1:500 WB), phospho-S6K (S371, #9208, 1:500 WB), LC3B (#2775,1:1000 WB, 1:100 IF), phospho-mTOR (S2448,#5536,1:1000 WB), mTOR (#2983, 1:1000 WB). Calnexin (#2679,1:1000 WB, 1:100 IF) were purchased from Cell

PEX2 is essential for the growth of HCC cells

Among peroxins, PEX2 was found to be overexpressed in hepatocellular carcinoma (HCC) tissues in three different studies (Supplementary Figs. S1A–C) [[23], [24], [25]]. Further, the copy number amplification (CNA) of PEX2 obtained from two liver cancer cohorts shows the amplification frequency of 11.4% (42 of 370 cases) and 3% (7 of 231 cases), in liver TCGA and liver AMC, respectively (Supplementary Fig. S1D). These data suggest that the gain of PEX2 copy number may contribute to the increased

Discussion

Peroxisomes play important metabolic functions in the body. They are essential in breaking down very long chain fatty acids (VLCFA), phytochemicals, etc., and in the synthesis of bile acids [9,40]. The enzymes involved in these metabolic reactions are imported into peroxisomes via the function of a group of proteins called peroxins. Deficiency in peroxins leads to the generation of empty peroxisomes or peroxisome membrane “ghosts” [9,41,42]. Although failed to be imported into peroxisomes,

Financial support statement

This study was supported by the National Natural Science Foundation (No. 81773032 and 31371362), and in part by grants from NIH to PZ (CA116097 and CA122623).

Conflicts of interest

The authors declare no potential conflicts of interest.

Acknowledgments

We thank the Imaging Facility of National Center for Protein Sciences-Beijing (NCPSB) for assistance with Microscopy imaging and image data analysis. We would thank Shanghai ProfLeader Biotech Co, Ltd for assistance with the metabolomics experiments and data analysis. The authors would also like to acknowledge Cell Imaging Facility, Technology Center for Protein Sciences, Tsinghua University for assistance of image analysis.

References (48)

  • I. Monastyrska et al.

    Autophagy in organelle homeostasis: peroxisome turnover

    Mol. Aspect. Med.

    (2006)
  • S. Nagotu et al.

    Molecular basis of peroxisomal biogenesis disorders caused by defects in peroxisomal matrix protein import

    Biochim. Biophys. Acta

    (2012)
  • A. Neuhaus et al.

    A novel Pex14 protein-interacting site of human Pex5 is critical for matrix protein import into peroxisomes

    J. Biol. Chem.

    (2014)
  • S. Thoms et al.

    Peroxisomal matrix protein receptor ubiquitination and recycling

    Biochim. Biophys. Acta

    (2006)
  • D.N. Tripathi et al.

    The peroxisome as a cell signaling organelle

    Curr. Opin. Cell Biol.

    (2016)
  • J. Wang et al.

    Bridges between mitochondrial oxidative stress, ER stress and mTOR signaling in pancreatic beta cells

    Cell. Signal.

    (2016)
  • H.R. Waterham et al.

    Genetics and molecular basis of human peroxisome biogenesis disorders

    Biochim. Biophys. Acta

    (2012)
  • M. Yamasaki et al.

    Formation of peroxisomes from peroxisomal ghosts in a peroxisome-deficient mammalian cell mutant upon complementation by protein microinjection

    J. Biol. Chem.

    (1999)
  • V.D. Antonenkov

    Dehydrogenases of the pentose phosphate pathway in rat liver peroxisomes

    Eur. J. Biochem.

    (1989)
  • V.D. Antonenkov et al.

    Peroxisomes are oxidative organelles

    Antioxidants Redox Signal.

    (2010)
  • M. Baes et al.

    Peroxisomes, myelination, and axonal integrity in the CNS

    Neuroscientist

    (2009)
  • D.I. Benjamin et al.

    Ether lipid generating enzyme AGPS alters the balance of structural and signaling lipids to fuel cancer pathogenicity

    Proc. Natl. Acad. Sci. U. S. A

    (2013)
  • M.V. Blagosklonny

    Hypoxia, MTOR and autophagy: converging on senescence or quiescence

    Autophagy

    (2013)
  • N.E. Braverman et al.

    Rhizomelic chondrodysplasia punctata type 1

  • Cited by (42)

    • Role and regulation of autophagy in cancer

      2022, Biochimica et Biophysica Acta - Molecular Basis of Disease
      Citation Excerpt :

      Furthermore, PEX2 expression along with PEX10 and PEX12 is also significantly increased in hepatocellular carcinoma (HCC) cells. It was also identified that the tumor growth is directly proportional and ROS production is indirectly proportional to PEX5 expression in liver cancer cells [141]. In lymphoma cells, downregulation of PEX3 reduces its resistance to Vorinostat (Vor) by triggering apoptosis [142].

    • Transcriptomic profiling of peroxisome-related genes reveals a novel prognostic signature in hepatocellular carcinoma

      2022, Genes and Diseases
      Citation Excerpt :

      Recent studies revealed that peroxisomes play an essential role in the development and progression of HCC.15 Specifically, multiple peroxisomal enzymes and related metabolic activities are altered in HCC and other cancers.16–20 Additionally, modulation of peroxisomal enzyme inhibitors and gene expression has been demonstrated to either inhibit or promote tumor growth.16,17,20

    View all citing articles on Scopus
    View full text